Aurora、COにおける前立腺がんの臨床試験
Auroraとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
被験者募集中第3相
- Rocky Mountain Regional VA Medical Center, Aurora
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
被験者募集中第3相
- UCHealth University of Colorado Hospital, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
被験者募集中第1相
- University of Colorado Anschutz Medical Campus, Aurora
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
被験者募集中第3相
- University of Colorado Anschutz Medical Campus ( Site 0046), Aurora
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
被験者募集中第2相
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
被験者募集中第2相
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
被験者募集中第3相
- Rocky Mountain Regional Veterans Affairs Medical Center ( Site 0053), Aurora
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
被験者募集中第3相
- UCHealth University of Colorado Hospital, Aurora
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
被験者募集中第3相
- Research Site, Aurora
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1相
- Rocky Mountain Cancer Centers, Aurora
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
被験者募集中第1/2相
- University of Colorado Health, Aurora
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University of Colorado, Aurora
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
被験者募集中第3相
- UCHealth University of Colorado Hospital, Aurora
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
被験者募集中第4相
- University of Colorado, Aurora
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
被験者募集中早期第1相
- Colorado Research Center, Aurora
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
被験者募集中第2相
- University of Colorado Anschutz Medical Campus, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Aurora
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
被験者募集中第3相
- University of Colorado Hospital, Aurora
他の都市における前立腺がんの試験
- New York City, NY103件の研究
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN43件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
Auroraにおける他の研究
- がん（全種類）35件の研究
- 大腸癌32件の研究
- 非小細胞肺癌31件の研究
- 乳がん28件の研究
- 卵巣がん25件の研究
- 転移性癌25件の研究
- 1型糖尿病23件の研究
- 肥満症22件の研究
- 肺がん19件の研究
- 心不全18件の研究
- 悪性黒色腫18件の研究
- 急性骨髄性白血病16件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。